When navigating drug discovery, it is critical to strategically balance project timelines and investments, and to select a reliable bioanalysis partner who is fully dedicated to the success of your program. Our ability to provide technical expertise and quick turnarounds will enable you to select your drug candidate and move on to the next phase of your project with ease and efficiency.
View our on-demand webinar where industry experts Edward Brewer, Senior Director of R&D, Mass Spectrometry and Systems Validation, and Ryan Adler, Manager of Laboratory Operations, cover:
- Advancements in Bioanalysis and strategic techniques used to quantify drug compounds during the discovery process.
- How our streamlined workflows enable fast and flexible decision-making and keep lead times down to 6-8 weeks.
- Navigating challenges faced during the discovery phase and exploring strategies to overcome these potential obstacles.
- How we advance molecules with ease and precision from Discovery to GLP.